AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Protara Therapeutics, Inc. Director's Dealing 2021

Apr 20, 2021

34057_dirs_2021-04-20_9759d5a8-8d95-4779-990f-8ae9053b0224.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2021-04-19

Reporting Person: Olivo Martin Sebastian (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4451	Direct